Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

VX-740 advances in preclinical studies

Jan. 2, 1998

UPSA claims new COX-2 inhibitors for inflammation, pain and other disorders

Dec. 31, 1997

FDA approves Arthrotec, a new arthritis medication with NSAID efficacy and improved GI safety

Dec. 30, 1997

New antiinflammatory compounds disclosed by Glycomed

Dec. 30, 1997

Alexion files IND for C5 inhibitor treatment for rheumatoid arthritis

Dec. 29, 1997

Phase IIb trial of TCR vaccine for rheumatoid arthritis begins

Dec. 29, 1997

Procter & Gamble's COX-2 inhibitor in preclinical testing

Dec. 24, 1997

Hyal discontinues development of osteoarthritis drug

Dec. 18, 1997

Pennsaid submitted to FDA for approval

Dec. 16, 1997

Selective COX-2 inhibitors under development at Merck Frosst

Dec. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...